Showing results (801-810 of 896) with videos related to

Sort By:
Pageof 90
BJU International|July 23, 2024
Identifying the facilitators and barriers to implementation of renal tumour biopsy in the diagnostic pathway for small renal massesVeronica Ranieri, Hannah Warren, Isabella Florez, et al.
World Journal of Urology|August 3, 2018
External validation of a predictive model of survival after cytoreductive nephrectomy for metastatic renal cell carcinomaLorenzo Marconi, Roderick de Bruijn, Erik van Werkhoven, et al.
Lancet (London, England)|September 13, 2022
Adjuvant atezolizumab versus placebo for patients with renal cell carcinoma at increased risk of recurrence following resection (IMmotion010): a multicentre, randomised, double-blind, phase 3 trialSumanta Kumar Pal, Robert Uzzo, Jose Antonio Karam, et al.
Urologic Oncology|September 20, 2022
Recurrence pattern in localized RCC: results from a European multicenter database (RECUR)Giuseppe Fallara, Alessandro Larcher, Saeed Dabestani, et al.
Nature Communications|April 22, 2024
PD-L1- and IL-4-expressing basophils promote pathogenic accumulation of T follicular helper cells in lupusJohn Tchen, Quentin Simon, Léa Chapart, et al.
International Journal of Surgery (London, England)|October 30, 2020
A cohort study of 30 day mortality after NON-EMERGENCY surgery in a COVID-19 cold siteVeeru Kasivisvanathan, Jamie Lindsay, Sara Rakshani-Moghadam, et al.
European Urology Open Science|January 15, 2026
Long-term Real-world Survival Outcomes with Dual Immune Checkpoint Blockade in Synchronous Metastatic Renal Cell Carcinoma: Implications for the Design of Prospective Cytoreductive Nephrectomy TrialsLeo Bickley, Elisabeth E Fransen van de Putte, Luna van den Brink, et al.
BJU International|October 27, 2021
Cytoreductive nephrectomy and exposure to sunitinib - a post hoc analysis of the Immediate Surgery or Surgery After Sunitinib Malate in Treating Patients With Metastatic Kidney Cancer (SURTIME) trialYasmin Abu-Ghanem, Johannes V van Thienen, Christian Blank, et al.
European Urology|May 14, 2014
Carbonic anhydrase 9 expression increases with vascular endothelial growth factor-targeted therapy and is predictive of outcome in metastatic clear cell renal cancerGrant D Stewart, Fiach C O'Mahony, Alexander Laird, et al.
BJU International|May 28, 2021
Growth and renal function dynamics of renal oncocytomas in patients on active surveillanceJoana B Neves, Rebecca Varley, Stefano Agnesi, et al.
Pageof 90